Aegis Therapeutics Overview

  • Year Founded
  • 2003

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 1

Aegis Therapeutics General Information

Description

Developer of drug delivery agents and formulations designed to support the non-invasive delivery of drugs into patients' systems. The company's products enable the systematic delivery of peptides protein, nucleotide-related, and other small and large molecule drugs without injections, allowing patients to eliminate the need for needles and disposal tissues.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • 11770 Bernardo Plaza Court
  • Suite 353
  • San Diego, CA 92130
  • United States
Primary Industry
Drug Delivery
Other Industries
Drug Discovery
Acquirer
Corporate Office
  • 11770 Bernardo Plaza Court
  • Suite 353
  • San Diego, CA 92130
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Aegis Therapeutics Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Aegis Therapeutics‘s full profile, request access.

Request a free trial

Aegis Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of drug delivery agents and formulations designed to support the non-invasive delivery of drugs into patients'
Drug Delivery
San Diego, CA

Madison, WI

Vancouver, Canada
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Aegis Therapeutics Competitors (15)

One of Aegis Therapeutics’s 15 competitors is Regenerative Medical Solutions, a Venture Capital-Backed company based in Madison, WI.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Regenerative Medical Solutions Venture Capital-Backed Madison, WI
Acuitas Therapeutics Corporation Vancouver, Canada
Acousia Therapeutics Venture Capital-Backed Tubingen, Germany
Thabor Therapeutics Venture Capital-Backed Paris, France
LEO Pharma Private Equity-Backed Ballerup, Denmark
You’re viewing 5 of 15 competitors. Get the full list »

Aegis Therapeutics Patents

Aegis Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-3969054-A1 Oil-soluble drug containing compositions and methods of use thereof Inactive 16-May-2019
EP-3969054-A4 Oil-soluble drug containing compositions and methods of use thereof Inactive 16-May-2019
US-20200360292-A1 Oil-soluble drug containing compositions and methods of use thereof Inactive 16-May-2019
WO-2020232379-A1 Oil-soluble drug containing compositions and methods of use thereof Inactive 16-May-2019
US-10682414-B2 Intranasal epinephrine formulations and methods for the treatment of disease Active 21-Dec-2018 A61K47/26
To view Aegis Therapeutics’s complete patent history, request access »

Aegis Therapeutics FAQs

  • When was Aegis Therapeutics founded?

    Aegis Therapeutics was founded in 2003.

  • Where is Aegis Therapeutics headquartered?

    Aegis Therapeutics is headquartered in San Diego, CA.

  • What industry is Aegis Therapeutics in?

    Aegis Therapeutics’s primary industry is Drug Delivery.

  • Is Aegis Therapeutics a private or public company?

    Aegis Therapeutics is a Private company.

  • What is Aegis Therapeutics’s current revenue?

    The current revenue for Aegis Therapeutics is .

  • Who are Aegis Therapeutics’s competitors?

    Regenerative Medical Solutions, Acuitas Therapeutics, Acousia Therapeutics, Thabor Therapeutics, and LEO Pharma are some of the 15 competitors of Aegis Therapeutics.

  • When was Aegis Therapeutics acquired?

    Aegis Therapeutics was acquired on 03-Dec-2018.

  • Who acquired Aegis Therapeutics?

    Aegis Therapeutics was acquired by Neurelis.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process